FDA approves new treatment for patients with migraine

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Reyvow is not indicated for the preventive treatment of...

Read More

Malaria Elimination Programme Receives Mahatma Award for Social Good

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

The Malaria Elimination Demonstration Project (MEDP) started by the Foundation for Disease Elimination and Control of India (FDEC India) was conferred with the Mahatma Award for Social Good 2019 at the 'Mahatma Awards’ ceremony held at Gurgaon, Delhi NCR as...

Read More

Interactive Meet on Food & Nutraceutical Sector held at Accuprec

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

An Interactive Meet on Food & Nutraceutical Sector was organised at Accuprec ResearchLab. Ms. Dipika Chauhan, Dy. Commissioner (Food) of FDCA - Government of Gujarat provided valuable guidance about QA & QC aspects in Food & Nutraceutical Sector. Shri Hiren...

Read More

Over 200 number of people participated in Mylan Hackathon

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Mylan Pharmaceuticals Private Limited announced the winners of its second edition of the Mylan Hackathon held in Bengaluru. The two-day event took place on October 13 and 14, at Mylan’s Global Centre in the city, where students and professionals connected...

Read More

Morepen Labs adds three new drugs – Rivaroxaban, Vildagliptin and UDCA to its API portfolio

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Morepen Laboratories Ltd. has developed and added three blockbuster drugs to its portfolio of Active Pharmaceutical Ingredients (APis) for sale in domestic and global markets. The three bulk drugs I APis are Rivaroxa ban (trade nameXarelto), Vildagliptin (trade names- Galvus,...

Read More

India & Germany signs MoU on Genomics

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

An MOU has been signed between All India Institute of Ayurveda (AIIA) under Ministry of AYUSH and Frankfurter Innovationszentrum Biotechnologie GmbH (FiZ) here today. The MoU signed by Prof. Tanuja Nesari Director AIIA and Dr Christian Garbe, Managing Director of...

Read More

Over 50 Lakh Benefit under Ayushman Bharat

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Prime Minister Narendra Modi lauded the efforts made in the health sector as India achieved a major milestone of providing benefit to over 50 Lakh people under the Ayushman Bharat Scheme. He said “An important milestone in the journey of...

Read More

SEPC Launches India IP Guide

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Services Exports Promotion Council (SEPC), set-up by the Ministry of Commerce & Industry, has brought out the India Intellectual Property (IP) Guide at Cannes in MIPCOM 2019, being held from 14-17, October 2019, for the Media and Entertainment (M&E) industry....

Read More

UCB Agrees to Acquire Ra Pharmaceuticals

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

UCB and Ra Pharmaceuticals Inc. (NASDAQ: RARX, Ra Pharma) announced today their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma. Under the terms of the agreement, Ra Pharma shareholders will receive US$ 48 in cash...

Read More

Glenmark Pharmaceuticals receives ANDA approval for Abiraterone Acetate Tablets

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic version of Zytiga Tablets, 250 mg, of Janssen Biotech, Inc. According...

Read More

7 million people receive record levels of lifesaving TB treatment but 3 million still miss out

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

WHO’s latest Global Tuberculosis Report has been released. TB incidence rate in India has decreased by almost 50,000 patients over the past one year. In 2017, India had 27.4 lakh TB patients which came down to 26.9 lakh in 2018....

Read More

Roche announces FDA approval of Xofluza (baloxavir marboxil) for people at high risk of developing i

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Roche announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XofluzaTM (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older who...

Read More

All medical devices to be regulated from December 1

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

NEW DELHI: The health ministry has proposed to notify all medical devices from December 1, expanding the span of regulation to ensure safety and efficacy of a variety of such products used for diagnosis, treatments and other medical interventions in...

Read More

Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generati

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

Sanofi today celebrates the inauguration of its new digital manufacturing facility in Framingham, Massachusetts, marking one of the world’s first digital facilities using intensified, continuous biologics production technology. The new facility features leading-edge technology that connects the production process with...

Read More

FSSAI Survey: Your Milk is Largely Safe

  • accuprec_admin
  • Comments : 0
  • June 30, 2021

The Food Safety and Standards Authority of India (FSSAI) today released the full report of the ‘National Milk Safety and Quality Survey 2018’. The survey results demolish the perception of large scale milk adulteration in the country. The survey has...

Read More

Accreditations